No products in the cart.
-
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 10mg/0.6ml Kwikpen (UK)
₦910,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 12.5mg/0.5ml x 4 Pre-filled Pens
₦1,820,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 12.5mg/0.6ml Kwikpen (UK)
₦975,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 15mg/0.5ml x 4 Pre-filled Pens
₦1,885,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 15mg/0.6ml Kwikpen (UK)
₦1,040,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 2.5mg/0.5ml x 4 Pre-filled Pens
₦1,560,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 2.5mg/0.6ml Kwikpen (UK)
₦715,000.00 -
Mounjaro 5mg/0.5ml x 4 Pre-filled Pens
₦1,625,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 5mg/0.6ml Kwikpen (UK)
₦780,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 7.5mg/0.5ml x 4 Pre-filled Pens
₦1,755,000.00 -
ABOUT MOUNJARO Mounjaro? is a prescription only medicine (POM) indicated for: the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise as monotherapy or in addition to other medicinal products. weight management, including weight loss and weight maintenance, as an adjunct to a reduced-calorie diet and increased physical activity in obese/overweight adults. Mechanism of action: Tirzepatide is a long-acting dual GIP and GLP-1 receptor agonist. Both receptors are present on the pancreatic ? and ? endocrine cells, heart, vasculature, immune cells (leukocytes), gut and kidney. GIP receptors are also present on adipocytes. In addition, both GIP and GLP-1 receptors are expressed in the areas of the brain important to appetite regulation. Tirzepatide is highly selective to human GIP and GLP-1 receptors. Tirzepatide has high affinity to both the GIP and GLP-1 receptors. Tirzepatide lowers body weight and body fat mass. The mechanisms associated with body weight and body fat mass reduction involve decreased food intake through the regulation of appetite and modulation of fat utilisation. Contraindications: Hypersensitivity to the active substance or to any of the excipients. Store in a refrigerator at 2?8?C.Mounjaro 7.5mg/0.6ml Kwikpen (UK)
₦845,000.00 -
Mounjaro is a prescription medication that contains tirzepatide, a novel injectable treatment for adults with type 2 diabetes. It is designed to improve glycemic control and may also aid in weight loss, making it a valuable addition to diabetes management plans.Mounjaro Injection
₦3,250,000.00 -
Mounjaro helps with weight loss by reducing your appetite, so you eat fewer calories. It also slows down how fast food leaves the stomach so you feel fuller for longer. However, this effect reduces over time. This action is mediated by the GLP-1 hormone in the body.Mounjaro Weekly Injection Pen
₦100.00 -
Key FeaturesFeaturesMount Two 13-32" MonitorsVESA 75 x 75 & 100 x 100mm CompatibleHeight Adjustable ArmsTilt & Swivel Support360? RotationIntegrated Cable ManagementSteel ConstructionClamps to Desks up to 3.5" ThickMounts to Grommets up to 4" DeepShow?LessThe?Mount-It! Full Motion Dual Monitor Desk Mount for 13-32" Monitors?lets you raise your monitors to an ergonomic position and work more efficiently. Designed for performance, this mount is made from high-strength steel for durability. It includes both clamp and grommet installation components to fit a variety of desks.? The?Mount-It! Full Motion Dual Monitor Desk Mount for 13-32" Monitors?lets you raise your monitors to an ergonomic position and work more efficiently. Designed for performance, this mount is made from high-strength steel for durability. It includes both clamp and grommet installation components to fit a variety of desks. The arms can be raised and lowered on the pole for easy height adjustment. Or, tilt and swivel your monitors for comfortable reading. Integrated cable management minimizes cable clutter for a streamlined setup.Additional FeaturesLoad capacity of up to 22 lb per armCompatible with VESA 75mm and 100mm hole patterns+/- 90? tilt+/- 180? swivel360? screen rotationPole height of 16"Durable steel constructionSpecificationsSKU: GE779EA3VOHMGNAFAMZProduct Line: Diplomat global tech-solutionsModel: Mount-itWeight (kg): 1Color: BlackMount-It! Full Motion Dual Monitor Desk Mount For 13-32″ Monitors
₦1,200,000.00